Evidence map›Paper›PMID 35600873›Full record

ArticleFrontiers in pharmacology2022

Kasimujiang Aximujiang, Kuerbannaimu Kaheman, Xilinguli Wushouer, Guixia Wu, Abulaiti Ahemaiti, Kurexi Yunusi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Heliyon · 2024
    Article
  7. Probiotics: Shaping the gut immunological responses.World journal of gastroenterology · 2024
    Article
  8. Ethanol Extract ofMarine drugs · 2024
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. [E.faecium QH06 alleviates TNBS-induced colonic mucosal injury in rats].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kasimujiang AximujiangDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China.
Kuerbannaimu KahemanDepartment of Rehabilitation Medicine, First Affiliated Hospital in Xinjiang Medical University, Urumqi, China.
Xilinguli WushouerDepartment of Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China.
Guixia WuDepartment of Physiology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China.
Abulaiti AhemaitiThe Functional Center, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China.
Kurexi YunusiUygur Medical College, Xinjiang Medical University, Urumqi, China.
Xinjiang Medical University · CNFirst Affiliated Hospital of Xinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ulcerative colitis (UC) is a chronic non-specific inflammatory bowel disease with complex pathogenesis. The intestinal flora disturbance affects the homeostasis of the intestinal environment, leading to metabolic imbalance and immune abnormalities of the host, contributing to the perpetuation of intestinal inflammation. We suggest that the combination of anti-inflammatory therapy and the regulation of intestinal flora balance may help in the treatment process. Previously, we used a combination treatment consisting of

Indexed as

HKLintestinal floraLactobacillus acidophilusmetabolomicsulcerative colitis

Identifiers

PMID35600873
PMCPMC9118348
OpenAlexW4225410845

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.